Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Lorenzi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Cancer Therapeutics|May 6, 2010
mRNA and microRNA expression profiles of the NCI-60 integrated with drug activitiesHongfang Liu, Petula D'Andrade, Stephanie Fulmer-Smentek, et al.
Organic Letters|February 14, 2003
New palladium(II)-catalyzed asymmetric 1,2-dibromo synthesisArab K El-Qisairi, Hanan A Qaseer, George Katsigras, et al.
Molecular Cancer Therapeutics|January 8, 2010
Multifactorial regulation of E-cadherin expression: an integrative studyWilliam C Reinhold, Mark A Reimers, Philip Lorenzi, et al.
Nanomaterials (Basel, Switzerland)|December 27, 2024
Pleozymes: Pleiotropic Oxidized Carbon Nanozymes Enhance Cellular Metabolic FlexibilityAnh T T Vo, Karthik Mouli, Anton V Liopo, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activityNicholas Blazanin, Xiaobing Liang, Iqbal Mahmud, et al.
Nature Communications|January 7, 2026
Loss of KDM6A-mediated genomic instability and metabolic reprogramming regulates response to therapeutic perturbations in bladder cancerPratishtha Singh, Ranit D'Rozario, Bidisha Chakraborty, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
IL-1β-mediated inflammatory signaling drives ineffective erythropoiesis in early-stage myelodysplastic syndromesVera Adema, Irene Ganan-Gomez, Feiyang Ma, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple MyelomaNatthakan Thongon, Feiyang Ma, Pamela Lockyer, et al.
Nature Communications|February 8, 2024
Targeting DNA2 overcomes metabolic reprogramming in multiple myelomaNatthakan Thongon, Feiyang Ma, Natalia Baran, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Cancer Therapeutics|May 6, 2010
mRNA and microRNA expression profiles of the NCI-60 integrated with drug activitiesHongfang Liu, Petula D'Andrade, Stephanie Fulmer-Smentek, et al.
Organic Letters|February 14, 2003
New palladium(II)-catalyzed asymmetric 1,2-dibromo synthesisArab K El-Qisairi, Hanan A Qaseer, George Katsigras, et al.
Molecular Cancer Therapeutics|January 8, 2010
Multifactorial regulation of E-cadherin expression: an integrative studyWilliam C Reinhold, Mark A Reimers, Philip Lorenzi, et al.
Nanomaterials (Basel, Switzerland)|December 27, 2024
Pleozymes: Pleiotropic Oxidized Carbon Nanozymes Enhance Cellular Metabolic FlexibilityAnh T T Vo, Karthik Mouli, Anton V Liopo, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activityNicholas Blazanin, Xiaobing Liang, Iqbal Mahmud, et al.
Nature Communications|January 7, 2026
Loss of KDM6A-mediated genomic instability and metabolic reprogramming regulates response to therapeutic perturbations in bladder cancerPratishtha Singh, Ranit D'Rozario, Bidisha Chakraborty, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
IL-1β-mediated inflammatory signaling drives ineffective erythropoiesis in early-stage myelodysplastic syndromesVera Adema, Irene Ganan-Gomez, Feiyang Ma, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple MyelomaNatthakan Thongon, Feiyang Ma, Pamela Lockyer, et al.
Nature Communications|February 8, 2024
Targeting DNA2 overcomes metabolic reprogramming in multiple myelomaNatthakan Thongon, Feiyang Ma, Natalia Baran, et al.
Pageof 1